After suspending visiting earlier in the year, we are now able to offer limited visiting to some wards at the discretion of the nurse in-charge.”
We recognise the impact that a long stay in hospital can have on families and the importance of maintaining strong communication. Our ward staff are keeping in touch with patients’ next of kin directly and our Patient Advice and Liaison Service (PALS) can help pass on personal messages from family and friends.
The Queen Alexandra Hospital is located just on the hill slopes of Portsdown Hill overlooking Portsmouth. It is conveniently situated for both the M27 and A3M.
Family members and carers play an important role in supporting patients during an episode of ill health. We are committed to the active involvement of family members, friends and carers during a hospital stay. Family members and carers play an important role in supporting patients during an episode of ill health.
More information on visiting hospital for an appointment.
If you've had experience of using our services and would like to make a comment then please contact the Patient Advice and Liaison Service (PALS). Your views are very important to us and we would like to hear where you think improvements are needed or where things have gone so well that you would like to share your thanks or gratitude with the staff involved. When things have not gone so well then you can be sure that we want to hear from you, so please get in touch with PALS.
During your stay in hospital you will meet a number of different members of staff. All members of staff wear name badges, but if you are not sure who someone is or what they do, please feel free to ask them to introduce themselves and explain what they do.
If you have any questions about your treatment, please ask a doctor or a nurse.
There are lots of opportunities for you to get involved with the Trust, from volunteering to attending our public meetings, our Annual General Meeting or our hospital open day which is held every year.
We welcome and value your feedback and use the views you share with us in a number of ways to learn and make improvements as well as sharing best practice. Feedback can be provided in a number of ways.
Date: 18 January 2022
Volunteers are needed for the latest COVID-19 vaccine booster study, launching in Portsmouth this week.
The COV-BOOST: Young Adults Fractional Dosing Sub-study will run at the Portsmouth Research Hub, part of Portsmouth Hospitals University NHS Trust.
The study is looking at the use of different COVID-19 vaccines and doses for giving a third dose in young adults.
The NIHR-supported study, which is led by University Hospital Southampton NHS Foundation Trust, is looking for local volunteers who:
The study is open to those who have previously tested positive for COVID-19, as well as those who have not tested positive for COVID-19 before.
Anyone interested in finding out more or taking part in the study can visit the COV-BOOST website, where they can complete the study questionnaire to see if they are eligible.
Participants will be reimbursed up to £225 for their time, inconvenience and travel, with boosters given in January and into February.
Young adults have a stronger immune response to vaccines than older adults, and results from COVID-19 vaccine studies have suggested that lower doses of the Pfizer or Moderna COVID-19 vaccines may give as good an immune response in young adults as higher doses. Lower doses may also be linked with fewer side effects or lower rates of already rare adverse events.
Using lower doses could allow existing stocks of vaccines to be given to more people, which is important while the need for vaccines is greater than the number of doses available globally.
Participants on the study will be randomly selected to receive one of the following doses:
The study will take place at 15 hospitals across England, Wales and Scotland, and will include a total of over 900 participants. All participants will be monitored throughout the study for any potential side effects and will have bloods taken to measure their immune responses on the day of their first visit and then two weeks, one month, three months and eight months following vaccination.
All the trial sites are working on ways of including people in research from a wide variety of backgrounds and individuals from ethnic minorities are encouraged to apply.
Professor Saul Faust, Chief Investigator and Director of NIHR Southampton Clinical Research Facility, said: “The first phase of the COV-BOOST study looked at the safety, immune responses and side-effects of seven COVID-19 vaccines when used as a third booster jab. The findings have helped shape the UK booster programme and given important evidence towards global vaccination efforts.
“In this next phase, we are looking for volunteers aged 18 to 30 to help us investigate the safety and side effect profile of giving lower doses of either the Pfizer or Moderna COVID-19 vaccines.
“If we find that giving a lower dose of these vaccines to young adults gives as good an immune response as a higher dose, this could have positive implications for global vaccine supply and may result in a lower side effect profile in this age group.
“Our vital COVID-19 vaccine research would not be possible without support from the public, who continue to step forward to take part in our studies. We need young adults from all backgrounds to take part in this new study and I would encourage anyone interested to visit the COV-BOOST website to find out more and sign up.”
Dr Linda Harndahl, Project Manager at the Portsmouth Research Hub, added: "We’re proud to have supported the first phase of the COV-BOOST study, which provided important data to inform the UK’s booster vaccination programme, and want to thank all our research participants for taking part.
"The opening of the next phase of the study provides another exciting opportunity for our local community to be part of the research response to the pandemic.
"We’re looking for young adults aged 18-30 and living in and around Portsmouth to take part in the study. Anyone interested can find out more and check if they’re eligible by visiting the COV-BOOST website."
Professor Andrew Ustianowski, National Clinical Lead for the UK NIHR COVID Vaccine Research Programme, said: "The COV-BOOST study has already provided the UK and other countries with extremely valuable data when it comes to understanding how we can boost populations and protect them against COVID-19. The latest phase of the study could also prove very useful and help identify if lower doses can be as effective whilst having other specific advantages.
"We cannot thank participants enough for their commitment to COVID-19 vaccine studies and encourage those who have not yet received a booster to sign up for this study. The UK research community and public have played a huge role working with the NHS and NIHR supported teams to identify several important COVID-19 treatments and vaccines over the last two years. This latest booster sub-study can build upon our strong vaccine data and likely help us find more efficient ways to use vaccine supplies."
The COV-BOOST study published its full initial results in the Lancet in December 2021, which found several COVID-19 vaccines were safe and boosted immunity and its early findings in September 2021 informed the UK’s booster programme.